Stryker logo

Stryker dividendNYSE: SYK

TTMAnnual

Dividend per share (last paid)

$0.80
$0.000.00%

30 September 2024

Dividend per share (next)

-

new highvs 3 years high
+26.98%vs 3 years low
Performance
Most recent0.0%
1 year+6.7%
3 years+27.0%
5 years+53.9%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend per share (last paid) performance

Most recent change
SYK0.0%
SNY+7.2%
BSX-
VRTX-
MDT0.0%
GILD0.0%
PFE0.0%
1 year change
SYK+6.7%
SNY+7.2%
BSX-
VRTX-
MDT+1.4%
GILD+2.7%
PFE+2.4%
3 years change
SYK+27.0%
SNY+5.6%
BSX-
VRTX-
MDT+11.1%
GILD+8.4%
PFE+7.7%
5 years change
SYK+53.9%
SNY+17.1%
BSX-
VRTX-
MDT+29.6%
GILD+22.2%
PFE+16.7%

Dividend per share (last paid) performance

SYKSNYBSXVRTXMDTGILDPFE
Most recent0.0%+7.2%--0.0%0.0%0.0%
1 year+6.7%+7.2%--+1.4%+2.7%+2.4%
3 years+27.0%+5.6%--+11.1%+8.4%+7.7%
5 years+53.9%+17.1%--+29.6%+22.2%+16.7%
FAQ

What is Stryker dividend per share (last paid)?

Stryker dividend per share (last paid) is $0.80

What is Stryker dividend per share (last paid) compared to its all-time maximum value?

Stryker dividend per share (last paid) is 100% of its all-time maximum value

How has Stryker dividend per share (last paid) changed over the year?

Over the past year, Stryker dividend per share (last paid) has increased by 6.7%. During the same period, Sanofi has increased by 7.2%, Medtronic has increased by 1.4%, Gilead Sciences has risen by 2.7%, Pfizer has grown by 2.4%

How has Stryker dividend per share (last paid) changed over the 3 years?

During the last 3 years, Stryker dividend per share (last paid) has increased by 27.0%. Over the same period, Sanofi has increased by 5.6%, Medtronic has increased by 11.1%, Gilead Sciences has risen by 8.4%, Pfizer has grown by 7.7%

How has Stryker dividend per share (last paid) changed over the 5 years?

For the past 5 years, Stryker dividend per share (last paid) has increased by 53.9%. In the same period, Sanofi has increased by 17.1%, Medtronic has increased by 29.6%, Gilead Sciences has risen by 22.2%, Pfizer has grown by 16.7%